Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Words, inclusivity, and the struggle for health equality

Biogen, Eisai say lecanemab has aced phase 3 Alzheimer’s study

Roche puts $70m into ArsenalBio’s programmable T-cell platform

UK’s Pheon is latest kid on the block in ADC sector

Vertex, CRISPR prep filing for gene-editing blood disorder therapy

Harbour BioMed

SARS-CoV-2

News/ News/ R&D

AbbVie begins trials of COVID-19 antibody therapy

Richard Staines AbbVie, coronavirus, COVID-19, Harbour BioMed, infectious diseases, R&D, Utrecht University 0 Comment

AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the

X

AbbVie begins trials of COVID-19 antibody therapy

https://pharmaphorum.com/news/abbvie-licenses-in-covid-19-antibody-therapy-from-harbour-utrecht-uni/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

GSK names Burberry's Julie Brown as its new CFO
FDA drops PreCert report, new digital health guidances
Whistleblower gets $250m as Biogen settles US kickbacks case
Daiichi Sankyo grabs first approval for blood cancer drug Ezharmia
Better Therapeutics files for FDA approval of diabetes DTx

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com